Anaes · Measurement & monitoring physics

Study design and the hierarchy of evidence

Also known as Hierarchy of evidence · Study design · Evidence-based anaesthesia · Critical appraisal · GRADE · Randomised controlled trials · Systematic reviews · Meta-analysis

Every anaesthetic decision — which induction agent, which airway device, which perioperative bundle — should be anchored in the best available evidence, and the framework that ranks that evidence is the hierarchy of study design. The model rests on six exam-critical ideas. First, the HIERARCHY OF EVIDENCE PYRAMID ranks designs from weakest to strongest: expert opinion and anecdote at the base, then case reports and case series, then case-control studies, then cohort studies, then randomised controlled trials, and systematic reviews with meta-analyses at the apex. Second, a CASE-CONTROL study is RETROSPECTIVE — it starts with the outcome and looks back for exposure — and reports an ODDS RATIO, making it efficient for rare diseases but carrying a high risk of bias. Third, a COHORT study is PROSPECTIVE — it starts with the exposure and follows forward for the outcome — and reports a RELATIVE RISK, with incidence, temporality, dropouts, and confounding as its profile. Fourth, a CROSS-SECTIONAL study takes a single SNAPSHOT, reports PREVALENCE, and cannot establish causality. Fifth, the RANDOMISED CONTROLLED TRIAL is the gold standard for therapy because RANDOMISATION distributes confounders equally, with allocation concealment, BLINDING, and INTENTION-TO-TREAT analysis protecting validity; the CONSORT statement guides its reporting. Sixth, SYSTEMATIC REVIEWS and META-ANALYSES (PRISMA reporting) pool the evidence for a single estimate, with heterogeneity, forest and funnel plots, and the GRADE framework rating quality as high, moderate, low or very low. Critical appraisal of an RCT uses the PICO framework. Built on the observational-design primer (Ramji 2022), the case-series appraisal introduction (Munn 2020), the cross-sectional account (Kesmodel 2018), the allocation-subversion case study (Kennedy 2017), the allocation-concealment and blinding assessment (Schulz 2001), the CONSORT 2010 guideline (Schulz 2010), the intention-to-treat account (Tripepi 2020), the PRISMA 2020 statement (Page 2021), the meta-analysis tutorial (Balduzzi 2019), the I-squared account (Borenstein 2017), the frailty-delirium meta-analysis (Gracie 2021), the ROBINS-I tool (Sterne 2016), the GRADE consensus (Guyatt 2008) and GRADE rating guideline (Balshem 2011), and the research-question guide (Aslam 2010).